# EDGAR Filing Document

**Accession Number:** 0000822663
**File Stem:** 0001753926-25-001238
**Filing Date:** 2025-8
**Character Count:** 25851
**Document Hash:** f901a882ac4ca09fc241cb526bf3ef67
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-25-001238.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0001753926-25-001238

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250805

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250805

**DATE AS OF CHANGE**: 20250805

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTERPARFUMS INC
- **CENTRAL INDEX KEY:** 0000822663
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133275609
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-16469
- **FILM NUMBER:** 251185799

**BUSINESS ADDRESS:**
- **STREET 1:** 551 FIFTH AVE
- **STREET 2:** STE 1500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10176
- **BUSINESS PHONE:** 2129832640

**MAIL ADDRESS:**
- **STREET 1:** 551 FIFTH AVENUE
- **STREET 2:** STE 1500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10176

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTER PARFUMS INC
- **DATE OF NAME CHANGE:** 19990715

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JEAN PHILIPPE FRAGRANCES INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? ipar-20250805.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 5, 2025

**Interparfums, Inc.**

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware**  | **0-16469** | **13-3275609** |
| (State or other jurisdiction of<br>incorporation or organization) | Commission<br>File Number | (I.R.S. Employer<br>Identification No.) |

---

**<u>551 Fifth Avenue, New York, NY 10176</u>**

<u>(Address of Principal Executive Offices)</u>

**<u>212.983.2640</u>**

(Registrant's Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange** <br>**on which registered** |
| Common Stock, $.001 par value per share | IPAR | The Nasdaq Stock Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**<u>Item</u> <u>2.02</u> <u>Results of Operations and Financial Conditions</u>**

Certain portions of our press release dated August 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

* The 1<sup>st</sup>, 2<sup>nd</sup> (consisting of a table), 4<sup>th</sup> , 5<sup>th</sup> , 8<sup>th</sup> through 12<sup>th</sup> full paragraphs relating to results of operations for the second quarter of 2025

* Part of the 3<sup>rd</sup> paragraph relating to results of operations for the second quarter of 2025

* The 13<sup>th</sup> paragraph relating to balance sheet items, cash flow, inventory and supply chain

* The 17<sup>th</sup> through 22<sup>nd</sup> paragraphs relating to the previously announced conference call scheduled for August 6, 2025

* The consolidated statements of income and consolidated balance sheets 

**<u>Item 7.01 Regulation FD Disclosure</u>**

Certain portions of our press release dated August 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

* Portion of the 3<sup>rd</sup> paragraph relating to anticipating headwinds for the remainder of the year, along with an action plan to hopefully overcome said headwinds

* The 6<sup>th</sup> paragraph relating to the previously announced license agreements for Longchamp, Off- White and Goutal, as well as the Solferino flagship store opening next month in Paris

* The 7<sup>th</sup> paragraph relating to the potential impact of tariffs, recent pricing strategies, upcoming fragrance launches and foreign exchange tailwinds on the Company as it enters the second half of 2025

* The 14<sup>th</sup> and 15<sup>th</sup> paragraphs relating to reaffirmance of the previously announced 2025 guidance for the Company

* The 23<sup>rd</sup> paragraph relating to forward-looking information

* The balance of such press release not otherwise incorporated by reference in Item 2.02. 

**<u>Item 8.01 Other Events</u>**

* The 16<sup>th</sup> paragraph relating to Dividends

**<u>Item</u> <u>9</u><u>.</u><u>0</u><u>1</u> <u>Financial Statements and Exhibits</u><u>.</u>**

---

| | |
|:---|:---|
| [99.1](ex991_1.htm) | [Our press release dated August 5, 2025](ex991_1.htm) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: August 5, 2025

---

| | |
|:---|:---|
| Interparfums, Inc. | Interparfums, Inc. |
| By: | /s/ Michel Atwood |
|  | Michel Atwood, |
|  | Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

![P1#yIS1](c50b79a9549cc22dd45c.jpg)

**<u>FOR IMMEDIATE RELEASE</u>**

**<u>INTERPARFUMS, INC. REPORTS 2025 SECOND QUARTER AND HALF YEAR RESULTS</u>**

***Reaffirms 2025 Sales and Earnings Guidance***

New York, New York, August 5, 2025, Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the second quarter and six months ended June 30, 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Financial Highlights:** <br> *($ in millions, except per share amounts)* | &nbsp;&nbsp; **Three Months Ended**<br> **June 30,** | &nbsp;&nbsp; **Three Months Ended**<br> **June 30,** | &nbsp;&nbsp; **Three Months Ended**<br> **June 30,** | **Six Months Ended**<br> **June 30,** | **Six Months Ended**<br> **June 30,** | **Six Months Ended**<br> **June 30,** |
| &nbsp;&nbsp; **Financial Highlights:** <br> *($ in millions, except per share amounts)* | &nbsp;&nbsp; **2025** | &nbsp;&nbsp; **2024** | &nbsp;&nbsp; **% Change** | **2025** | **2024** | **% Change** |
| &nbsp;&nbsp; Net Sales  | &nbsp;&nbsp; $334  | &nbsp;&nbsp; $342  | &nbsp;&nbsp; (2%)  | $673  | $666  | +1%  |
| &nbsp;&nbsp; Gross Margin  | &nbsp;&nbsp; 66.2%  | &nbsp;&nbsp; 64.5%  | &nbsp;&nbsp; +170 bps  | 65.0%  | 63.5%  | +150 bps  |
| &nbsp;&nbsp; Operating Income  | &nbsp;&nbsp; $59  | &nbsp;&nbsp; $65  | &nbsp;&nbsp; (9%)  | $134  | $133  | +1%  |
| &nbsp;&nbsp; Operating Margin  | &nbsp;&nbsp; 17.7%  | &nbsp;&nbsp; 18.9%  | &nbsp;&nbsp; (120) bps  | 20.0%  | 19.9%  | +10 bps  |
| &nbsp;&nbsp; Net Income attributable to Interparfums, Inc.  | &nbsp;&nbsp; $32  | &nbsp;&nbsp; $37  | &nbsp;&nbsp; (13%)  | $74  | $78  | (4%)  |
| &nbsp;&nbsp; Diluted EPS  | &nbsp;&nbsp; $0.99  | &nbsp;&nbsp; $1.14  | &nbsp;&nbsp; (13%)  | $2.32  | $2.41  | (4%)  |
| *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* | *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* | *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* | *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* | *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* | *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* | *The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively.* |

---

**Operational Commentary**

Jean Madar, Chairman & Chief Executive Officer of Interparfums, noted, "Demand in the United States, which accounted for 35% of our second quarter net sales, remains strong, even as growth in the global fragrance market has begun to ease off. We are confident in our ability to navigate this environment thanks to the strength of our brand portfolio and our global network of distributors and retail partners, which give us access to a wide range of consumers across markets. While second quarter results were affected, and we anticipate that some of these headwinds will persist into the second half of the year, our proactive and timely actions position us to fully resolve these challenges in 2026.

"Our two largest markets, North America and Western Europe, grew sales by 7% and 3% on a year-to-date basis. Asia-Pacific fragrance sales were down 12% for the first half, with the decline primarily due to last year's exceptional sales in Australia and distribution disruptions in South Korea in the current year while the overall trend remains positive in China and Japan.

"Central & South America sales increased 7% during the first six months, propelled by the strong performance of Lacoste fragrances and healthy market growth. Sales in Eastern Europe were up 14% as compared to the first half of 2024, where we faced temporary sourcing constraints. The Middle East & Africa declined 19%, primarily due to a disproportionate impact from the exit of the Dunhill license; excluding the impact of Dunhill, net sales declined 6% due to conflict in the region and as more doors focused on higher end luxury fragrances.

"As announced last month, we signed an exclusive global license agreement with Longchamp, further strengthening our portfolio. This marks the third new brand we have added to our portfolio since December 2024, preceded by Off-White and Goutal. Additionally, our first owned brand fragrance collection, Solférino, remains on track with a highly selective distribution and elevated merchandising strategy as we prepare to open our flagship Paris boutique next month.

Mr. Madar concluded, "As always, we remain committed to investing in our brands and capabilities while maintaining the flexibility to adapt to evolving market conditions. Although the imposition of tariffs and a dynamic market environment may present near-term challenges due to trade destocking, our recent pricing strategies, upcoming fragrance launches, and foreign exchange tailwinds are expected to be the catalysts in driving stronger results in the second half of 2025 leading to continued market share gains."

------

**Financial Commentary**

Michel Atwood, Chief Financial Officer of Interparfums, noted, "Consolidated gross margin expanded 170 bps to 66.2% and 150 bps to 65.0% in the second quarter and first half of 2025, respectively, as a result of favorable segment and brand mix.

"SG&A expenses as a percentage of net sales were 48.5% and 45.0% for the second quarter and first half of 2025 as compared to 45.6% and 43.6% for the comparable periods in 2024, attributable to higher levels of advertising and promotional expenditures in 2025. These expenditures represented 20.6% and 17.9% of net sales for the second quarter and first half of 2025, compared to 19.4% and 17.2% for the respective periods of the prior year.

"The key metrics mentioned resulted in operating margins aggregating 17.7% and 20.0% for the second quarter and first half of 2025, respectively, as compared to 18.9% and 19.9% for the corresponding periods of 2024.

"Below the operating line, first half net income was unfavorably impacted by other expenses of $6.7 million compared to $1.5 million in last year's first half. Through June 30, 2025, we recorded $2.4 million in losses on foreign currency and a $3.4 million loss on marketable securities, while in the same period last year, there was a foreign currency gain of $0.3 million and a loss of $0.6 million on marketable securities.

"These factors contributed to our second quarter net income of $32 million, or $0.99 per diluted share.

"Our financial position remains healthy with $205 million in cash, cash equivalents and short-term investments, and working capital of $654 million. In the first half of 2025, we improved our operating cash flow by $31 million compared to the same period last year, shifting from $26 million of cash consumption to $5 million of cash generation as our inventory initiatives began to deliver results."

**Reaffirms 2025 Guidance**

Mr. Atwood concluded, "Despite healthy sellout in the first half driven by the strength of our portfolio and disciplined execution, our sales were slightly below expectations due to continued trade destocking. As we look ahead to the second half, we remain mindful of the ongoing macroeconomic uncertainty, including tariff-related supply chain impacts, moderating demand in several international markets outside the United States, and continued volatility of the EUR/USD exchange rate.

"Nevertheless, we are cautiously optimistic in our ability to achieve the full year objectives we initially laid out in November 2024, supported by the continued resilience of the fragrance category, tariff induced second half pricing actions, and continuing foreign exchange tailwinds. As such, we are reaffirming our 2025 guidance, which calls for net sales of $1.51 billion and earnings per diluted share of $5.35."

**Dividend**

The Company's regular quarterly cash dividend of $0.80 per share will be paid on September 30, 2025, to shareholders of record on September 15, 2025.

------

**Conference Call**

Management will host a conference call to discuss financial results and business operations beginning at 11:00 am ET on Wednesday, August 6, 2025.

Interested parties may participate in the live call by dialing:

U.S. / Toll-free: (877) 423-9820

International: (201) 493-6749

Participants are asked to dial-in approximately 10 minutes before the conference call is scheduled to begin.

A live audio webcast will also be available in the "Events" tab within the Investor Relations section of the Company's website at www.interparfumsinc.com, or by clicking here. The conference call will be available for webcast replay for approximately 90 days following the live event.

**About Interparfums, Inc.:**

Operating in the global fragrance business since 1982, Interparfums, Inc. produces and distributes a wide array of prestige fragrance and fragrance related products under license and other agreements with brand owners. The Company manages its business in two operating segments, European based operations, through its 72% owned subsidiary, Interparfums SA, and United States based operations, through wholly owned subsidiaries in the United States and Italy.

Our portfolio of prestige brands includes Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Donna Karan/DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Longchamp, MCM, Moncler, Montblanc, Oscar de la Renta, Roberto Cavalli, and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world through an extensive and diverse network of distributors. Interparfums, Inc. is also the registered owner of several trademarks including Lanvin, Rochas, and Solférino. Goutal and Off-White will join the Company's fragrance portfolio in 2026.

**Forward-Looking Statements**

Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as "anticipate, "believe", "could", "estimate", "expect", "intend", "may", "should", "will", and "would" or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings "Forward Looking Statements" and "Risk Factors" in Interparfums' annual report on Form 10-K for the fiscal year ended December 31, 2024, and the reports Interparfums files from time to time with the Securities and Exchange Commission. Interparfums does not intend to and undertakes no duty to update the information contained in this press release.

---

| | | |
|:---|:---|:---|
| **Contact Information:** |  |  |
| Interparfums, Inc. | or | The Equity Group Inc. |
| Michel Atwood |  | Karin Daly |
| Chief Financial Officer |  | Investor Relations Counsel |
| (212) 983-2640 |  | (212) 836-9623 / kdaly@theequitygroup.com |
| www.interparfumsinc.com |  | www.theequitygroup.com |

---

See Accompanying Tables

------

***INTERPARFUMS, INC. AND SUBSIDIARIES***

***CONSOLIDATED BALANCE SHEETS***

 *(In thousands except share and per share data)*

 *(Unaudited)*

 

---

| | | |
|:---|:---|:---|
| ***ASSETS*** |  |  |
|  | **June 30,** **2025** | **December 31, 2024** |
| &nbsp;&nbsp;&nbsp; **Current assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash and cash equivalents  | $151454 | $125433 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Short-term investments  | 53901 | 109311 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable, net  | 296043 | 274705 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories  | 425349 | 371920 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivables, other  | 8133 | 6122 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other current assets  | 50083 | 27035 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income taxes receivable  | 2024 | 306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current assets  | 986987 | 914832 |
| &nbsp;&nbsp;&nbsp; **Property, equipment and leasehold improvements, net** | 185356 | 153773 |
| &nbsp;&nbsp;&nbsp; **Right-of-use assets, net** | 23328 | 24603 |
| &nbsp;&nbsp;&nbsp; **Trademarks, licenses and other intangible assets, net** | 333353 | 282484 |
| &nbsp;&nbsp;&nbsp; **Deferred tax assets** | 12618 | 17034 |
| &nbsp;&nbsp;&nbsp; **Other assets** | 20106 | 18535 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total assets** | $1561748 | $1411261 |
| &nbsp;&nbsp;&nbsp; ***LIABILITIES AND EQUITY*** |  |  |
| &nbsp;&nbsp;&nbsp; **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loans payable - banks  | $44536 | $8311 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current portion of long-term debt  | 56745 | 41607 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current portion of lease liabilities  | 6250 | 6087 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts payable – trade  | 93146 | 91049 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses  | 126753 | 172758 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income taxes payable  | 5571 | 12615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities  | 333001 | 332427 |
| &nbsp;&nbsp;&nbsp; **Long–term debt, less current portion** | 153112 | 115734 |
| &nbsp;&nbsp;&nbsp; **Lease liabilities, less current portion** | 18883 | 20455 |
| &nbsp;&nbsp;&nbsp; **Equity:** |  |  |
| Interparfums, Inc. shareholders' equity:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Preferred stock, $.001 par; authorized 1,000,000 shares; none issued  | —  | —  |
| &nbsp;&nbsp;&nbsp;&nbsp; Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,117,600 and 32,110,170 shares at June 30, 2025 and December 31, 2024, respectively  | 32 | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp; Additional paid-in capital  | 108802 | 106702 |
| &nbsp;&nbsp;&nbsp;&nbsp; Retained earnings  | 787031 | 763240 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accumulated other comprehensive loss  | (1599 ) | (72239 ) |
| &nbsp;&nbsp;&nbsp;&nbsp; Treasury stock, at cost, 10,001,665 and 9,981,665 shares at June 30, 2025 and December 31, 2024, respectively  | (54907 ) | (52864 ) |
| Total Interparfums, Inc. shareholders' equity  | 839359 | 744871 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noncontrolling interest  | 217393 | 197774 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total equity  | 1056752 | 942645 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total liabilities and equity** | $1561748 | $1411261 |

---

 

------

***INTERPARFUMS, INC. AND SUBSIDIARIES***

***CONSOLIDATED STATEMENTS OF INCOME***

*(In thousands except per share data)*

 *(Unaudited)* 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Net sales** | $333936 | $342229 | $672755 | $666192 |
| **Cost of sales** | 112847 | 121472 | 235689 | 243050 |
| **Gross margin** | 221089 | 220757 | 437066 | 423142 |
| **Selling, general and administrative expenses** | 161913 | 155929 | 302813 | 290341 |
| **Income from operations** | 59176 | 64828 | 134253 | 132801 |
| **Other expenses (income):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest expense  | 1787 | 1941 | 3332 | 3748 |
| &nbsp;&nbsp;&nbsp; Loss (gain) on foreign currency  | 1580 | 634 | 2360 | (270 ) |
| &nbsp;&nbsp;&nbsp; Interest and investment loss (income)  | 1929 | 1076 | 1349 | (1944 ) |
| &nbsp;&nbsp;&nbsp; Other income  | (245 ) | (74 ) | (324 ) | (37 ) |
|  | 5051 | 3577 | 6717 | 1497 |
| **Income before income taxes** | 54125 | 61251 | 127536 | 131304 |
| Income taxes  | 12928 | 14653 | 30936 | 31403 |
| **Net income** | 41197 | 46598 | 96600 | 99901 |
| &nbsp;&nbsp;&nbsp; Less: Net income attributable to the noncontrolling interest  | 9209 | 9775 | 22120 | 22030 |
| **Net income attributable to Interparfums, Inc.** | $31988 | $36823 | $74480 | $77871 |
| **Earnings per share:** |  |  |  |  |
| **Net income attributable to Interparfums, Inc. common shareholders:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic  | $1.00 | $1.15 | $2.32 | $2.43 |
| &nbsp;&nbsp;&nbsp; Diluted  | $0.99 | $1.14 | $2.32 | $2.41 |
| **Weighted average number of shares outstanding:**  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic  | 32110 | 32024 | 32115 | 32033 |
| &nbsp;&nbsp;&nbsp; Diluted  | 32149 | 32266 | 32162 | 32266 |
| **Dividends declared per share** | $0.80 | $0.75 | $1.60 | $1.50 |

---

------